SCHAMBYE HANS T. (Chief Executive Officer) sold 13.0% of their position (700.00 shares) of DAMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $15.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/6/2026ACC: 0001193125-26-004573
DirectorOfficer· Chief Executive Officer
Since Oct 2020
-700.00
Net shares
Net seller
$15.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.36K acquired · 2.06K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.36K
Price / share
—
Trade value
—
% of position
33.8%
1/2/2026
4.02K→5.38K
Common Stock
Direct
Shares
−700.00
Price / share
$21.38
Trade value
$14.97K
% of position
13.0%
1/2/2026
5.38K→4.68K
Total
Net shares
+660.00
Net value
-$14.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | M · Option Exercise | +1.36K | — | — | 33.8% | 4.02K | 5.38K |
| Common Stock Direct | 1/2/2026 | S · Sale | −700.00 | $21.38 | $14.97K | 13.0% | 5.38K | 4.68K |
| Total | +660.00 | -$14.97K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
1.36K shares
Shares
−1.36K
Strike price
Held after
2.64K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.36K shares | 1/2/2026 | M · Option Exercise | −1.36K | — | 2.64K |